Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page reflects a minor update to the site/interface release version, changing the displayed revision number from v3.5.2 to v3.5.3 without altering the study details.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.3 is now displayed on the page, replacing the prior Revision: v3.4.2. This update concerns revision history metadata and does not alter the study content.SummaryDifference0.0%

- Check91 days agoChange DetectedRemoved the old government funding operating-status notice and the prior Revision: v3.4.1; added Revision: v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, informing users that information may not be up to date and the NIH Clinical Center is open with status updates at opm.gov. The page version indicator was updated to Revision: v3.4.1 and the previous Revision: v3.4.0 was removed.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.